Spanish plasma-based medicines maker Grifols has announced disappointing top-line data from its Phase III PRECIOSA clinical ...

Denmark introduces a three-year agreement to regulate price ceilings for hospital medicines, with phased reductions totaling ...

The US Court of Appeals for the Federal Circuit on Friday affirmed a lower district court order against Israeli ...

French pharma major Sanofi says it has entered into a new chapter of the collaboration with South Korean firm SK bioscience ...

US pharma giant Pfizer on Friday revealed that the US Food and Drug Administration (FDA) has approved its Braftovi ...

The US Food and Drug Administration (FDA) on Friday approved an expanded indication for Imcivree (setmelanotide), from Boston ...

US drugmaker Vertex Pharmaceuticals’ shares were unmoved on Friday, despite receiving two new regulatory authorizations.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorization for ...

Denmark’s Novo Nordisk said late Friday that the US Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) ...

San Diego, USA-based Neurocrine Biosciences today announced the launch of its Crenessity (crinecerfont) in the USA.

Zealand Pharma faces a setback as the FDA issues a complete response letter for glepaglutide, requiring a new Phase III trial ...

Epitopea partners with Genevant Sciences to develop RNA-based cancer immunotherapies targeting proprietary tumor antigens.